|Venue||Finnstown Country House Hotel, Newcastle Rd, Lucan|
|Date||Thursday, September 7th , 2017|
|Time||7:30 am - 9:30 am|
The cost effectiveness of medicines, along with the reimbursement process in the Irish healthcare market is a source of much continued debate. Following on from our Market Update breakfast with Orlaith Brennan of IPHA we are delighted to host Professor Michael Barry Clinical Director of the National Centre for Pharmacoeconomics at a breakfast seminar on September 7th.
Professor Michael Barry, Clinical Director with National Centre for Pharmaeconomics
Prof. Michael Barry is a Consultant Clinical Pharmacologist and Head of the Department of Pharmacology & Therapeutics at the University of Dublin, Trinity College. He is the clinical director of the National Centre for Pharmacoeconomics which conducts pharmacoeconomic evaluations on medicines prior to reimbursement under the Community Drugs schemes in Ireland. He is Past-President (2010-2011) of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He was a board member of the Health Information and Quality Authority (HIQA) and is a member of a number of National Committees on pricing and reimbursement of medicines. Prof. Barry chairs the New Drugs Committee and the Medication Safety Committee at St. James’s Hospital, Dublin. In 2013 he was appointed as Clinical Lead for the new HSE Medicines Management Programme. He is a fellow of the Royal College of Physicians in Ireland and is a specialty trainer for Pharmacology & Therapeutics. His research areas include the cost-effectiveness of high cost drugs including chemotherapeutic agents and biologic drugs, pricing and reimbursement and performance based risk sharing schemes. He has published widely on the cost-effectiveness of medicines in the Irish healthcare setting.
This event is now FULLY BOOKED
This event is kindly sponsored by:
This event is fully booked.